192 related articles for article (PubMed ID: 2117850)
1. Evaluation and therapy of the patient with fecal occult blood loss: a decision analysis.
Lashner BA; Silverstein MD
Am J Gastroenterol; 1990 Sep; 85(9):1088-95. PubMed ID: 2117850
[TBL] [Abstract][Full Text] [Related]
2. Screening for colorectal cancer: the cost to find an advanced adenoma.
McGrath JS; Ponich TP; Gregor JC
Am J Gastroenterol; 2002 Nov; 97(11):2902-7. PubMed ID: 12425566
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of colorectal cancer screening strategies in Singapore: a dynamic decision analytic approach.
Wong SS; Leong AP; Leong TY
Stud Health Technol Inform; 2004; 107(Pt 1):104-10. PubMed ID: 15360784
[TBL] [Abstract][Full Text] [Related]
4. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
5. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
[TBL] [Abstract][Full Text] [Related]
6. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
Inadomi JM
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
[TBL] [Abstract][Full Text] [Related]
7. Barium enema and endoscopy for the detection of colorectal neoplasia: sensitivity, specificity, complications and its determinants.
de Zwart IM; Griffioen G; Shaw MP; Lamers CB; de Roos A
Clin Radiol; 2001 May; 56(5):401-9. PubMed ID: 11384140
[TBL] [Abstract][Full Text] [Related]
8. Rectosigmoid polyps as markers of proximal colonic neoplasms: a cost benefit analysis of different diagnostic protocols.
Arrigoni A; Pennazio M; Rossini FP
Anticancer Res; 1995; 15(2):563-7. PubMed ID: 7763038
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of diagnostic examinations for colorectal polyps.
Menardo G
Tech Coloproctol; 2004 Dec; 8 Suppl 2():s273-5. PubMed ID: 15666105
[TBL] [Abstract][Full Text] [Related]
10. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.
Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M;
J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of early colonoscopy surveillance after cancer resection.
Hassan C; Pickhardt PJ; Zullo A; Di Giulio E; Laghi A; Kim DH; Iafrate F
Dig Liver Dis; 2009 Dec; 41(12):881-5. PubMed ID: 19467938
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of colorectal cancer screening.
McMahon PM; Bosch JL; Gleason S; Halpern EF; Lester JS; Gazelle GS
Radiology; 2001 Apr; 219(1):44-50. PubMed ID: 11274533
[TBL] [Abstract][Full Text] [Related]
13. Testing for occult cancer in patients with idiopathic deep vein thrombosis--a decision analysis.
Barosi G; Marchetti M; Dazzi L; Quaglini S
Thromb Haemost; 1997 Nov; 78(5):1319-26. PubMed ID: 9408012
[TBL] [Abstract][Full Text] [Related]
14. Colonoscopy evaluations: justification by cost?
Rex DK; Mark D; Clarke B; Lappas JC; Lehman GA
Am J Gastroenterol; 1996 Mar; 91(3):614-5. PubMed ID: 8633528
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer. Which test is best?
Cahill BA
Adv Nurse Pract; 2005 Jan; 13(1):71-4. PubMed ID: 15679298
[No Abstract] [Full Text] [Related]
16. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.
Greenberg PD; Bertario L; Gnauck R; Kronborg O; Hardcastle JD; Epstein MS; Sadowski D; Sudduth R; Zuckerman GR; Rockey DC
Am J Gastroenterol; 2000 May; 95(5):1331-8. PubMed ID: 10811348
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests.
Heresbach D; Chauvin P; Grolier J; Josselin JM
Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341
[TBL] [Abstract][Full Text] [Related]
18. Strategies for screening for colorectal carcinoma.
England WL; Halls JJ; Hunt VB
Med Decis Making; 1989; 9(1):3-13. PubMed ID: 2492069
[TBL] [Abstract][Full Text] [Related]
19. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
20. [Determination of cost-effective strategies in colorectal cancer screening].
Dervaux B; Eeckhoudt L; Lebrun T; Sailly JC
Rev Epidemiol Sante Publique; 1992; 40(5):296-306. PubMed ID: 1480806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
